Key Segments
By Treatment Type
- Pharmacological Treatments
- Laxatives
- NSAIDs
- Corticosteroids
- Local Anesthetics
- Herbals
- Others (e.g., flavonoids, vasoconstrictors, astringents)
- Non-Surgical Procedures
- Rubber Band Ligation
- Sclerotherapy
- Infrared Coagulation
- Cryotherapy
- Surgical Procedures
- Hemorrhoidectomy
- Stapled Hemorrhoidopexy
By Route of Administration
- Oral
- Topical
- Rectal
By Type
- Internal Hemorrhoids
- External Hemorrhoids
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- Egypt
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Aging populations are more prone to constipation and chronic venous insufficiency, leading to increased hemorrhoid incidence and thus driving higher demand for both medical and surgical treatments.
Topical treatments, suppositories, and non-surgical procedures like rubber band ligation are widely used due to convenience and efficacy in early-stage hemorrhoids.
Key players include Abbott, Sanofi, Bayer, Church & Dwight, GlaxoSmithKline, Boston Scientific, and Sebela Pharmaceuticals, offering both drug-based and device-assisted treatments.
Minimally invasive procedures like infrared coagulation, laser therapy, and radiofrequency ablation are gaining traction due to shorter recovery times and reduced postoperative complications.
North America holds the largest market share due to high healthcare expenditure and awareness, while the Asia-Pacific region is the fastest-growing due to improving access to healthcare and an increasing patient pool.
Get in Touch
